Low calretinin expression and high neutrophil-to-lymphocyte ratio are poor prognostic factors in patients with malignant mesothelioma undergoing extrapleural pneumonectomy.
about
Advances in the diagnosis, treatment and prognosis of malignant pleural mesotheliomaPrognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysisThe Multifaceted Roles Neutrophils Play in the Tumor MicroenvironmentBiomarkers and prognostic factors for mesotheliomaPosttranscriptional Regulation Controls Calretinin Expression in Malignant Pleural Mesothelioma.Malignant pleural mesothelioma: predictors and stagingSupplementary prognostic variables for pleural mesothelioma: a report from the IASLC staging committee.A serum mesothelin level is a prognostic indicator for patients with malignant mesothelioma in routine clinical practice.The South West Area Mesothelioma and Pemetrexed trial: a multicentre prospective observational study evaluating novel markers of chemotherapy response and prognosticationMiR-score: a novel 6-microRNA signature that predicts survival outcomes in patients with malignant pleural mesothelioma.Factors associated with survival in a large series of patients with malignant pleural mesothelioma in New South WalesKi67 index is an independent prognostic factor in epithelioid but not in non-epithelioid malignant pleural mesothelioma: a multicenter study.The tumoral and stromal immune microenvironment in malignant pleural mesothelioma: A comprehensive analysis reveals prognostic immune markersClinical role of a new prognostic score using platelet-to-lymphocyte ratio in patients with malignant pleural mesothelioma undergoing extrapleural pneumonectomy.Cancer-specific stress and mood disturbance: implications for symptom perception, quality of life, and immune response in women shortly after diagnosis of breast cancerMicroRNA gene expression signatures in long-surviving malignant pleural mesothelioma patients.Inflammation in malignant mesothelioma - friend or foe?Radical surgery for malignant pleural mesothelioma: have we identified the appropriate selection tools?Existing models, but not neutrophil-to-lymphocyte ratio, are prognostic in malignant mesotheliomaMalignant pleural mesothelioma: current and future perspectivesIdentification of cis- and trans-acting elements regulating calretinin expression in mesothelioma cellsCalretinin expression in high-grade invasive ductal carcinoma of the breast is associated with basal-like subtype and unfavorable prognosis.An RNAi-based screen reveals PLK1, CDK1 and NDC80 as potential therapeutic targets in malignant pleural mesothelioma.CD74: a new prognostic factor for patients with malignant pleural mesothelioma.Challenges and controversies in the diagnosis of malignant mesothelioma: Part 2. Malignant mesothelioma subtypes, pleural synovial sarcoma, molecular and prognostic aspects of mesothelioma, BAP1, aquaporin-1 and microRNA.Expression of Wilms' tumor gene (WT1) is associated with survival in malignant pleural mesothelioma.Diagnosis and prognosis-review of biomarkers for mesothelioma.Prognostic significance of neutrophil-to-lymphocyte ratio in patients with malignant pleural mesothelioma: a meta-analysisClinical staging of malignant pleural mesothelioma: current perspectives.Mesothelin Expression in Gastric Adenocarcinoma and Its Relation to Clinical OutcomesPrognostic value of the lymphocyte-to-monocyte ratio and other inflammatory markers in malignant pleural mesothelioma.Intrathoracic solitary fibrous tumor - an international multicenter study on clinical outcome and novel circulating biomarkers.Response to comment on 'Existing prognostic models, but not neutrophil-to-lymphocyte ratio, are prognostic in malignant mesothelioma'.The value of inflammatory parameters in the prognosis of malignant mesothelioma.The role of the systemic inflammatory response in predicting outcomes in patients with operable cancer: Systematic review and meta-analysis.Health-related quality of life and inflammatory markers in malignant pleural mesothelioma.Clinical and biologic prognostic factors in malignant pleural mesothelioma.Relation between neutrophil/lymphocyte ratio and primary tumor metabolic activity in patients with malign pleural mesothelioma.Regulation of calretinin in malignant mesothelioma is mediated by septin 7 binding to the CALB2 promoter.Overexpressed genes in malignant pleural mesothelioma: implications in clinical management.
P2860
Q26787294-6EC8DFAF-A938-4A94-AD49-5A4213708157Q27022482-2D983943-B6E5-4515-8CF7-84D7725CF9A0Q28241308-D34677DB-7EDB-4706-B33C-E3592D30B0E5Q28387194-DF2CC494-0654-4A6D-B7A7-C2AD26930CDDQ33734673-8AEF9431-B1C8-4A13-870C-506DB5824B5CQ33871571-8BFF5D40-E79C-4E6C-9D36-0710968524A6Q34041728-4E4CDB1B-A7BC-4935-9061-B1ACE9D9B714Q34278435-2383136B-7AA8-46B7-920C-C26E9A8F25D8Q35274923-BFDFE977-E692-494F-A5BB-9F0652C306FFQ35511541-7BD6C422-EBA3-4164-AECB-5F66D4E145FEQ35678085-9CDA39B0-FEAC-4F07-B081-847E08CC07CAQ35678741-BA6FB261-00DD-4638-A060-A63E740380F8Q35799028-F052DB52-A307-4014-BB23-D7D51210812AQ36345736-13AE797A-207F-4CC8-9D82-149984351610Q36515709-EB49BD50-3216-4B50-8E37-C8F74A5343A3Q37049227-D4253BBA-AC37-4106-B9CE-659E9CCAC244Q37090789-9E6BE806-1B21-49B5-88E2-200DB267ACC7Q37090803-723082F0-81A2-4624-B50A-8E790C7FC74BQ37214250-213E8746-E74E-4100-ACCB-C229EF33B096Q37217764-7754EA15-9A9C-473A-978C-128EE9E89462Q37225261-7F5AEE29-D7B9-459F-8B3A-3FA2B68A0CD5Q37338128-D6E2A9BF-9845-4095-9D8E-F6DD162EFC56Q37507415-10C2539D-2B3E-430E-93BC-772EF6994B27Q37711647-570713FE-BE9A-4496-B092-175FC5E43D6EQ38119922-06F2887F-A5AC-45FC-8653-42EB653CD2F6Q39298123-BA261188-28B7-415C-B62E-5F9E02B35707Q39434249-2B8B7856-30FD-4667-A920-4A66F0149E58Q41341293-146487BF-E223-4E2E-B93B-8ECE8EFA6A48Q41522440-0AADA550-FB91-4098-AD68-0D70D06C9D61Q41992584-028BB98B-DDBC-40BF-99C7-AACE2095A2F3Q42000248-FBED0E25-FC48-4A7C-8B92-8C97A2D07478Q42035019-6CBC4192-C9D8-44E7-BCFF-4F9011E64D52Q42585963-7F553BAF-EC78-447E-89E1-72822E369572Q43595658-AE467402-C9DB-4B04-8A04-DB98B0AADE96Q47338550-C1D45FC6-2FF7-4512-9012-1AD7A9F5D58CQ48394328-0AA069A5-9C39-45CC-8CB9-14621AC7E979Q50050310-1EF93284-B5DE-47C2-B443-52EC9C1BEB79Q51757335-08CCD7C7-3051-41E4-A7AE-9D29EEA492A7Q52560706-82B6AA1F-AD30-41A4-AE40-FC7A80029ABBQ52672878-10FEA53C-3FE7-49C7-B2BB-32BF6D3DD1EB
P2860
Low calretinin expression and high neutrophil-to-lymphocyte ratio are poor prognostic factors in patients with malignant mesothelioma undergoing extrapleural pneumonectomy.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Low calretinin expression and ...... ng extrapleural pneumonectomy.
@en
Low calretinin expression and ...... ng extrapleural pneumonectomy.
@nl
type
label
Low calretinin expression and ...... ng extrapleural pneumonectomy.
@en
Low calretinin expression and ...... ng extrapleural pneumonectomy.
@nl
prefLabel
Low calretinin expression and ...... ng extrapleural pneumonectomy.
@en
Low calretinin expression and ...... ng extrapleural pneumonectomy.
@nl
P2093
P50
P1476
Low calretinin expression and ...... ing extrapleural pneumonectomy
@en
P2093
Brian McCaughan
Douglas W Henderson
Sonja Klebe
Stephen Clarke
Steven Chuan-Hao Kao
Tristan D Yan
P304
P356
10.1097/JTO.0B013E31822A3740
P577
2011-11-01T00:00:00Z